Investing

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation…

By Joel South
Published June 13, 2026, 9:30am ET · 4 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A futuristic digital image featuring glowing blue and green tones. An upward-curving arrow, composed of intertwining data streams, dominates the center, pointing towards growth. Below it are three illuminated icons: a molecular structure on the left, a caduceus symbol in the middle, and a shield icon on the right. In the blurred background, abstract representations of DNA helices, cells, and stock market candlestick charts with an upward trend are visible, all contributing to a theme of innovation and progress in the medical and financial fields.
This visual illustrates the dynamic potential for growth and innovation within the healthcare sector, reflecting investment opportunities in promising medical stocks. © 24/7 Wall St.

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation has left a handful of high-margin operators trading at forward multiples that look out of step with their cash generation. Here are three to put on the radar this month.

Contact [email protected] for any questions or corrections.

Joel South

Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.

He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.

All articles →